Instead, contact both your prescribing provider and our eye office promptly so we can assess whether the vision changes require immediate attention or simply closer monitoring while continuing therapy
Another notable treatment, Zepbound (tirzepatide), utilizes a dual GIP/GLP-1 receptor agonist approach for amplified weight loss
Novo Nordisk, the drugmaker behind Ozempic, has been ramping up its legal blitz of knockoffs of its weight loss and diabetes drug
Compounded versions of semaglutide are not FDA-approved products, though the active ingredient itself has FDA approval for weight management through brand-name formulations
Adults with the following conditions can use it: Weight issues Weight-related medical conditions such as hypertension, sleep apnea, or type 2 diabetes The main difference between Ozempic and Wegovy is dosage: Wegovy is prescribed at a higher maintenance dose, which often leads to greater weight loss in studies